                </a></li></ul></div><p><strong>Figure 2.  <span>Prenatal daytime cocaine exposure dose-dependently alters expression of genes involved in neurotransmission (A) circadian system (B, C) growth (D) and melatonin signaling (E), and these effects are counteracted by melatonin.</span></strong></p><a id="article1.body1.sec2.sec1.fig2.caption1.p1" name="article1.body1.sec2.sec1.fig2.caption1.p1"></a><p>(A–E) Melatonin (100 nM for 45 min), Low (0.3 µM) or High (30 µM) cocaine doses (15 min), with or without melatonin pre-treatment (100 nM, 30 min). (F) Melatonin receptor antagonist Luzindole attenuates the counteracting effects of melatonin on cocaine-induced changes in the expression of all six melatonin receptor genes; only one (<em>zMel1a-1</em>) receptor shown. Treatments: luzindole 50 µM for 20 min prior to melatonin; melatonin 100 nM for 20 min prior to cocaine; cocaine 0.3 µM for 15 min. (G) Dose-dependent effects of cocaine (20 min) on melatonin receptor expression. Y axis: fold change relative to control ( = 1). N = 3–4 samples/treatment group, 25 embryos/sample. Mean±SEM, <em>t</em>-test (vs. control), * <em>p</em>&lt;0.05, ** <em>p</em>&lt;0.01, *** <em>p</em>&lt;0.001; One way ANOVA (between treatments), a: <em>p</em>&lt;0.05, vs. cocaine-only group. Mlt-melatonin; Coc-cocaine.</p>
<span>THISISTHEEND
